-
Je něco špatně v tomto záznamu ?
Unicentric form of Castleman ́s disease, pitfalls of diagnosis and surgical treatment
J. Molacek, V. Treska, T. Skalicky, J. Vodicka, J. Ferda, E. Ferdova, J. Baxa, C. Mach, A. Jungova, M. Michal
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu systematický přehled
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- Publikační typ
- systematický přehled MeSH
BACKGROUND: Castleman ́s disease is an extremely rare heterogenous lymphoproliferative pathology with a mostly benign behavior. It is a localized or generalized lymph node enlargement of an unknown aetiology. Unicentric form is typically a slow-growing solitary mass occurring mostly in the mediastinum, abdominal cavity, retroperitoneum, pelvis and neck. Aetiology and pathogenesis of CD is probably diverse, varying in different types of this heterogeneous disease. MATERIALS AND METHODS: Authors present a review of this issue based on their extensive experience. The aim is to summarize the crucial factors in the management of diagnostics and a surgical treatment of the unicentric form of Castleman ́s disease. One of the key issues in the unicentric form is precise preoperative diagnostics and thus choosing the right surgical treatment strategy. Authors highlight pitfalls of the diagnosis and surgical treatment. RESULTS: All histological types such as a hyaline vascular type, plasmacytic type and a mixed type are presented as well as options of surgical and conservative treatment. Differential diagnosis and malignant potential is discussed. CONCLUSION: Patients with Castleman ́s disease should be treated in the high- volume centers, with a great experience in major surgical procedures as well as with preoperative imaging diagnostic techniques. Specialized pathologists and oncologists focusing on this issue are also absolutely necessary to avoid misdiagnosis. Only this complex approach can lead to excellent outcomes in patients with UCD.
Department of Hematology and Oncology University Hospital in Pilsen Plzen Czechia
Department of Imaging Methods Faculty of Medicine in Pilsen Charles University Pilsen Czechia
Department of Surgery Faculty of Medicine in Pilsen Charles University Pilsen Czechia
Faculty of Medicine in Pilsen Charles University Plzen Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003060
- 003
- CZ-PrNML
- 005
- 20240117094700.0
- 007
- ta
- 008
- 230413s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fonc.2023.1057683 $2 doi
- 035 __
- $a (PubMed)36793610
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Molacek, Jiri $u Faculty of Medicine in Pilsen, Charles University, Plzen, Czechia $u Department of Surgery, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 245 10
- $a Unicentric form of Castleman ́s disease, pitfalls of diagnosis and surgical treatment / $c J. Molacek, V. Treska, T. Skalicky, J. Vodicka, J. Ferda, E. Ferdova, J. Baxa, C. Mach, A. Jungova, M. Michal
- 520 9_
- $a BACKGROUND: Castleman ́s disease is an extremely rare heterogenous lymphoproliferative pathology with a mostly benign behavior. It is a localized or generalized lymph node enlargement of an unknown aetiology. Unicentric form is typically a slow-growing solitary mass occurring mostly in the mediastinum, abdominal cavity, retroperitoneum, pelvis and neck. Aetiology and pathogenesis of CD is probably diverse, varying in different types of this heterogeneous disease. MATERIALS AND METHODS: Authors present a review of this issue based on their extensive experience. The aim is to summarize the crucial factors in the management of diagnostics and a surgical treatment of the unicentric form of Castleman ́s disease. One of the key issues in the unicentric form is precise preoperative diagnostics and thus choosing the right surgical treatment strategy. Authors highlight pitfalls of the diagnosis and surgical treatment. RESULTS: All histological types such as a hyaline vascular type, plasmacytic type and a mixed type are presented as well as options of surgical and conservative treatment. Differential diagnosis and malignant potential is discussed. CONCLUSION: Patients with Castleman ́s disease should be treated in the high- volume centers, with a great experience in major surgical procedures as well as with preoperative imaging diagnostic techniques. Specialized pathologists and oncologists focusing on this issue are also absolutely necessary to avoid misdiagnosis. Only this complex approach can lead to excellent outcomes in patients with UCD.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a systematický přehled $7 D000078182
- 700 1_
- $a Treska, Vladislav $u Department of Surgery, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 700 1_
- $a Skalicky, Tomas $u Department of Surgery, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 700 1_
- $a Vodicka, Josef $u Department of Surgery, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 700 1_
- $a Ferda, Jiri $u Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 700 1_
- $a Ferdova, Eva $u Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 700 1_
- $a Baxa, Jan $u Department of Imaging Methods, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia
- 700 1_
- $a Mach, Christiana $u Department of Surgery, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czechia $7 xx0269340
- 700 1_
- $a Jungova, Alexandra $u Department of Hematology and Oncology, University Hospital in Pilsen, Plzen, Czechia
- 700 1_
- $a Michal, Michael $u Faculty of Medicine in Pilsen, Charles University, Plzen, Czechia
- 773 0_
- $w MED00182989 $t Frontiers in oncology $x 2234-943X $g Roč. 13, č. - (2023), s. 1057683
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36793610 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230413 $b ABA008
- 991 __
- $a 20240117094656 $b ABA008
- 999 __
- $a ok $b bmc $g 1922760 $s 1189267
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 13 $c - $d 1057683 $e 20230130 $i 2234-943X $m Frontiers in oncology $n Front Oncol $x MED00182989
- LZP __
- $a Pubmed-20230413